Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruchit Shah

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Cureus|July 15, 2021
Prominent Thebesian Veins in Association With Takotsubo CardiomyopathyPriyadarshini Dixit, Ruchi Shah, Yashwant Agrawal, et al.
Future Oncology (London, England)|February 2, 2022
Treatment patterns and economic burden among newly diagnosed cervical and endometrial cancer patientsChizoba Nwankwo, Ruchit Shah, Anuj Shah, et al.
Journal of Medical Economics|October 23, 2021
Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States populationRuchit Shah, Shelby Corman, Anuj Shah, et al.
Future Oncology (London, England)|January 31, 2022
Treatment patterns and economic burden among cervical and endometrial cancer patients newly initiating systemic therapyNehemiah Kebede, Ruchit Shah, Anuj Shah, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 21, 2023
Quality-adjusted time without symptoms or toxicity analysis of nivolumab plus chemotherapy versus chemotherapy alone for the management of previously untreated patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinomaDaniel Lin, Hiep Nguyen, Ruchit Shah, et al.
Future Oncology (London, England)|July 21, 2023
The burden of ovarian cancer in the USA from 2007 to 2018: evidence from the Medical Expenditure Panel SurveyElizabeth A Szamreta, Wei-Jhih Wang, Ruchit Shah, et al.
Patient Related Outcome Measures|March 4, 2021
Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by <i>Mycobacterium avium</i> Complex (MAC)Anuj Shah, Xinyi Ng, Ruchit Shah, et al.
Cureus|September 16, 2022
Ventricular Arrhythmias in a Patient With Propionic AcidemiaAnthony A Della Rossa, Priyadarshini M Dixit, Ruchit Shah, et al.
Journal of Medical Economics|December 15, 2019
Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapyAnuj Shah, Ruchit Shah, Nehemiah Kebede, et al.
Frontiers in Medicine|March 24, 2015
Knowing What's Out There: Awareness of Non-Alcoholic Fatty Liver DiseaseVishal Ghevariya, Nan Sandar, Kishor Patel, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Cureus|July 15, 2021
Prominent Thebesian Veins in Association With Takotsubo CardiomyopathyPriyadarshini Dixit, Ruchi Shah, Yashwant Agrawal, et al.
Future Oncology (London, England)|February 2, 2022
Treatment patterns and economic burden among newly diagnosed cervical and endometrial cancer patientsChizoba Nwankwo, Ruchit Shah, Anuj Shah, et al.
Journal of Medical Economics|October 23, 2021
Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States populationRuchit Shah, Shelby Corman, Anuj Shah, et al.
Future Oncology (London, England)|January 31, 2022
Treatment patterns and economic burden among cervical and endometrial cancer patients newly initiating systemic therapyNehemiah Kebede, Ruchit Shah, Anuj Shah, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 21, 2023
Quality-adjusted time without symptoms or toxicity analysis of nivolumab plus chemotherapy versus chemotherapy alone for the management of previously untreated patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinomaDaniel Lin, Hiep Nguyen, Ruchit Shah, et al.
Future Oncology (London, England)|July 21, 2023
The burden of ovarian cancer in the USA from 2007 to 2018: evidence from the Medical Expenditure Panel SurveyElizabeth A Szamreta, Wei-Jhih Wang, Ruchit Shah, et al.
Patient Related Outcome Measures|March 4, 2021
Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by <i>Mycobacterium avium</i> Complex (MAC)Anuj Shah, Xinyi Ng, Ruchit Shah, et al.
Cureus|September 16, 2022
Ventricular Arrhythmias in a Patient With Propionic AcidemiaAnthony A Della Rossa, Priyadarshini M Dixit, Ruchit Shah, et al.
Journal of Medical Economics|December 15, 2019
Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapyAnuj Shah, Ruchit Shah, Nehemiah Kebede, et al.
Frontiers in Medicine|March 24, 2015
Knowing What's Out There: Awareness of Non-Alcoholic Fatty Liver DiseaseVishal Ghevariya, Nan Sandar, Kishor Patel, et al.
Pageof 5